Alkermes Receives Fda Fast Track Designation For Nemvaleukin Alfa In Combination With Pembrolizumab…
- Second Fast Track Designation for Nemvaleukin -
Alkermes plc announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track…